|
FY2013
12 months to Dec 31, 2013
|
FY2012
12 months to Dec 31, 2012
|
FY2011
12 months to Dec 31, 2011
|
FY2010
12 months to Dec 31, 2010
|
|
|---|---|---|---|---|
| REVENUES: | ||||
| Net pharmaceutical product sales | ||||
| Devices revenues | ||||
| Other revenues | ||||
| TOTAL REVENUES | ||||
| COSTS AND EXPENSES: | ||||
| Cost of revenues | ||||
| Selling, general and administrative | ||||
| Research and development | ||||
| Impairment of other intangible assets | ||||
| Patent litigation settlement, net | ||||
| Litigation-related and other contingencies | ||||
| Asset impairment charges | ||||
| Acquisition-related and integration items | ||||
| OPERATING (LOSS) INCOME FROM CONTINUING OPERATIONS | ||||
| INTEREST EXPENSE, NET | ||||
| LOSS ON EXTINGUISHMENT OF DEBT | ||||
| OTHER (INCOME) EXPENSE, NET | ||||
| (LOSS) INCOME FROM CONTINUING OPERATIONS BEFORE INCOME TAX | ||||
| INCOME TAX | ||||
| (LOSS) INCOME FROM CONTINUING OPERATIONS | ||||
| DISCONTINUED OPERATIONS, NET OF TAX (NOTE 3) | ||||
| CONSOLIDATED NET (LOSS) INCOME | ||||
| Less: Net income attributable to noncontrolling interests | ||||
| NET (LOSS) INCOME ATTRIBUTABLE TO ENDO HEALTH SOLUTIONS INC. | ||||
| NET (LOSS) INCOME PER SHARE ATTRIBUTABLE TO ENDO HEALTH SOLUTIONS INC. COMMON STOCKHOLDERS—BASIC: | ||||
| Continuing operations, basic (usd per share) | ||||
| Discontinued operations, basic (usd per share) | ||||
| Basic (usd per share) | ||||
| Continuing operations, diluted (usd per share) | ||||
| Discontinued operations, diluted (usd per share) | ||||
| Diluted (usd per share) | ||||
| WEIGHTED AVERAGE SHARES: | ||||
| Basic (shares) | ||||
| Diluted (shares) |
Loading...
